Scarica l'app Stockscreener
51.95
2.30%
1.17
Precedente Chiudi:
$50.78
Aprire:
$51.04
Volume 24 ore:
3.12M
Relative Volume:
0.65
Capitalizzazione di mercato:
$9.24B
Reddito:
$803.32M
Utile/perdita netta:
$-709.10M
Rapporto P/E:
-6.66
EPS:
-7.8003
Flusso di cassa netto:
$-212.68M
1 W Prestazione:
-5.39%
1M Prestazione:
-22.64%
6M Prestazione:
-25.39%
1 anno Prestazione:
-37.97%
Intervallo 1D:
$50.43
$52.65
Intervallo di 1 settimana:
$49.40
$57.98
Portata 52W:
$36.22
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Nome
Tempus Ai Inc
Settore
Industria
Telefono
800-976-5448
Indirizzo
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, DOCS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
51.95 | 9.03B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
VEEV
Veeva Systems Inc
|
174.11 | 28.27B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
BTSG
Brightspring Health Services Inc
|
38.86 | 6.82B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
73.88 | 6.25B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
25.02 | 4.56B | 550.17M | 201.35M | 232.07M | 1.00 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-10-21 | Downgrade | TD Cowen | Buy → Hold |
| 2025-10-20 | Iniziato | Canaccord Genuity | Buy |
| 2025-09-02 | Iniziato | H.C. Wainwright | Buy |
| 2025-04-21 | Iniziato | BTIG Research | Buy |
| 2025-02-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Ripresa | TD Cowen | Buy |
| 2024-12-13 | Iniziato | Wolfe Research | Outperform |
| 2024-12-09 | Iniziato | Guggenheim | Buy |
| 2024-11-11 | Downgrade | Stifel | Buy → Hold |
| 2024-10-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-12 | Iniziato | Piper Sandler | Neutral |
| 2024-07-09 | Iniziato | BofA Securities | Buy |
| 2024-07-09 | Iniziato | JP Morgan | Overweight |
| 2024-07-09 | Iniziato | Longbow | Buy |
| 2024-07-09 | Iniziato | Loop Capital | Buy |
| 2024-07-09 | Iniziato | Morgan Stanley | Overweight |
| 2024-07-09 | Iniziato | Needham | Buy |
| 2024-07-09 | Iniziato | Stifel | Buy |
| 2024-07-09 | Iniziato | TD Cowen | Buy |
| 2024-07-09 | Iniziato | William Blair | Outperform |
Mostra tutto
Tempus Ai Inc Borsa (TEM) Ultime notizie
Can Tempus AI Inc. stock sustain revenue growthJuly 2025 Opening Moves & Weekly High Return Opportunities - mfd.ru
Looking Into Tempus AI Inc's Recent Short Interest - Sahm
Should You Buy, Hold or Sell Tempus AI Stock Pre-Q4 Earnings Release? - The Globe and Mail
Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis® LCS Software as a Medical Device in the United States - BioSpace
Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform - 01net
Tempus AI, Inc. Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform - marketscreener.com
Mitchell Capital Management Co. Purchases Shares of 70,338 Tempus AI, Inc. $TEM - MarketBeat
Tempus AI Inc (TEM) Trading Down 4.78% on Feb 11 - GuruFocus
Best Artificial Intelligence Stocks To ConsiderFebruary 11th - MarketBeat
HIMS Dips 55.8% in 3 Months: Should You Still Hold the Stock or Sell? - TradingView
Jim Cramer on Tempus (TEM): "It's Going to Go Back Down Again" - Finviz
Jim Cramer on Tempus (TEM): “It’s Going to Go Back Down Again” - Insider Monkey
Tempus AI Stock (TEM) Opinions on Short Seller Report - Quiver Quantitative
Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24 - marketscreener.com
AI in Oncology Research and Long-term Forecasts Report 2026-2040: Siemens Healthineers and GE Healthcare Lead, While NVIDIA, IBM, Tempus, PathAI, and Emerging Specialists Expand Use Cases - Yahoo Finance
Stock Report: Is Tempus AI Inc stock risky to hold nowJuly 2025 Final Week & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Artificial Intelligence Stocks Worth WatchingFebruary 8th - MarketBeat
Top Artificial Intelligence Stocks To Keep An Eye OnFebruary 7th - MarketBeat
Artificial Intelligence Stocks To Follow NowFebruary 6th - MarketBeat
IQ EQ FUND MANAGEMENT IRELAND Ltd Boosts Stock Position in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI Shares Jump After FDA Approves Updated Cardiac Imaging Platform - MSN
Do Tempus AI’s New IPS Results Reframe TEM’s Edge In Precision Oncology Diagnostics? - Yahoo Finance
Best Artificial Intelligence Stocks To ResearchFebruary 5th - MarketBeat
Can Tempus AI’s (TEM) Immune Profile Score Redefine Its Edge In Precision Oncology Data? - simplywall.st
Tempus AI Links Hereditary Cancer Data And Immune Scoring To Growth Prospects - Yahoo Finance
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Globe and Mail
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Motley Fool
Tempus AI, Inc. (TEM): A Bull Case Theory - Finviz
Insider Sell: David Epstein Sells 370 Shares of Tempus AI Inc (T - GuruFocus
Tempus AI (NASDAQ:TEM) Director Sells $21,981.70 in Stock - MarketBeat
Promising Artificial Intelligence Stocks To Watch NowFebruary 4th - MarketBeat
RSI Alert: Tempus AI (TEM) Now Oversold - Nasdaq
Tempus AI Stock (TEM) Opinions on Q4 Earnings Beat - Quiver Quantitative
New DNA study could sharpen cancer risk for thousands of patients - stocktitan.net
Tempus AI, Inc. (NASDAQ:TEM) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
AI in Oncology Market to Reach US$ 22.85 Billion by 2033, Growing - openPR.com
Best Artificial Intelligence Stocks To Watch TodayFebruary 2nd - MarketBeat
Tempus AI, Inc. (TEM) Investor Outlook: Navigating a 46.97% Upside Amidst High Growth and Strategic Collaborations - DirectorsTalk Interviews
What's Going On With Tempus AI Stock Monday?Tempus AI (NASDAQ:TEM) - Benzinga
RNA in cancer gene tests found 1 in 25 positives otherwise missed - stocktitan.net
Artificial Intelligence Stocks To Keep An Eye OnFebruary 1st - MarketBeat
Tempus AI, Inc. (TEM) Strengthens Precision Medicine with New Tools, Partnerships, and Growth Milestones - Finviz
Mirae Asset Global Investments Co. Ltd. Increases Stake in Tempus AI, Inc. $TEM - MarketBeat
Artificial Intelligence Stocks To Follow TodayJanuary 31st - MarketBeat
Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells 166,250 Shares of Stock - MarketBeat
Promising Artificial Intelligence Stocks To Watch TodayJanuary 30th - MarketBeat
Tempus AI Enhances AI-Driven Diagnostics With Multiple FDA Approvals - MSN
Tempus AI Inc (TEM) Trading Down 4.09% on Jan 30 - GuruFocus
Esoteric Testing Research Report 2026 - GlobeNewswire Inc.
Is Tempus AI Inc. stock a good dividend stockWeekly Trade Review & Community Verified Swing Trade Signals - mfd.ru
Tempus AI's COO Ryan Fukushima sells shares worth $2.27 million - MSN
Tempus Ai Inc Azioni (TEM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Tempus Ai Inc Azioni (TEM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Tempus AI, Inc. | 10% Owner |
Nov 25 '25 |
Buy |
10.62 |
23,600 |
250,665 |
12,918,346 |
| Tempus AI, Inc. | 10% Owner |
Dec 22 '25 |
Buy |
8.93 |
28,000 |
250,040 |
13,039,067 |
| Tempus AI, Inc. | 10% Owner |
Nov 21 '25 |
Buy |
9.40 |
26,499 |
249,190 |
12,869,521 |
| Tempus AI, Inc. | 10% Owner |
Nov 24 '25 |
Buy |
9.87 |
25,225 |
248,971 |
12,894,746 |
| Tempus AI, Inc. | 10% Owner |
Nov 19 '25 |
Buy |
8.12 |
30,645 |
248,837 |
12,814,195 |
| Tempus AI, Inc. | 10% Owner |
Nov 20 '25 |
Buy |
8.63 |
28,827 |
248,777 |
12,843,022 |
| Tempus AI, Inc. | 10% Owner |
Dec 17 '25 |
Buy |
7.86 |
31,650 |
248,769 |
12,949,996 |
| Tempus AI, Inc. | 10% Owner |
Dec 19 '25 |
Buy |
8.39 |
29,641 |
248,688 |
13,011,067 |
| Tempus AI, Inc. | 10% Owner |
Dec 18 '25 |
Buy |
7.91 |
31,430 |
248,611 |
12,981,426 |
| Epstein David R | Director |
Feb 02 '26 |
Sale |
59.41 |
370 |
21,982 |
26,051 |
2.83%
1.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):